Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin–angiotensin–aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients-Reference-Cited by-同舟云学术

Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin–angiotensin–aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients

Published:2011-10 Issue:10 Volume:29 Page:2031-2037
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Weir Matthew R.,Hollenberg Norman K.,Remuzzi Giuseppe,Zappe Dion H.,Meng Xiangyi,Parving Hans-Henrik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference18 articles.

1. Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.;van de Wal;Hypertension,2006

2. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.;De Cosmo;Diabetes,2009

3. Genetic variant of the renin-angiotensin system and diabetes influences blood pressure response to angiotensin receptor blockers.;Konoshita;Diabetes Care,2009

4. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.;Volkan-Salanci;J Renin Angiotensin Aldosterone Syst,2009

5. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.;Parving;N Engl J Med,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. Aliskiren in an alternate-day administration schedule in hypertensive albuminuric patients;Blood Pressure Monitoring;2014-12

3. Plasma Aldosterone Is Increased in Class 2 and 3 Obese Essential Hypertensive Patients Despite Drug Treatment;American Journal of Hypertension;2012-07-01